Dear readers,
Your retina is no longer just a biological lens; it is a timestamp. By analyzing a single retinal image, algorithms can now identify Parkinson’s markers seven years before first symptoms. This is not science fiction. It was showcased two weeks ago at our Adopt AI international Summit 2025 at the Grand Palais.
Welcome to the second edition of Artefact’s Healthcare Quarterly.
As this level of diagnostic precision, and many other real-world applications, now exist, the conversations about AI have abandoned the conditional tense. We stopped asking “what if.” Instead, we watched a digital twin convince a rare cancer to retreat by reducing a drug dose by 30%. Consequently, the industry has moved past the era of “hype” into the era of tangible value measurement.
Beyond the patient-visible transformations, AI is being integrated on a large scale into organizational processes. Major treatment discovery and development organisations are now using AI in every project.
However, these transformations are not just about building ‘smarter’ models, they are about building trust. Indeed, the large-scale adoption of AI, particularly in Europe, is still hindered by significant challenges related to data fragmentation, regulatory compliance, and public trust.
This newsletter delivers 50 replays from the summit designed to help you grasp the speed of innovation. We hope you find this edition both insightful and actionable, and we look forward to discussing the future of healthcare together
Paul de Balincourt (Healthcare Consulting Partner), Ahmed Fares (Healthcare Consulting Manager), and Jade Haine-Dubourg (Healthcare Consultant)
The Agentic AI Advantage in Healthcare: Accelerating Pharma’s HCP-Centric Marketing from Insight to Outcome
Pharma commercial teams face growing complexity, from more demanding launches to reduced HCP access, while existing systems struggle to keep pace. Success now depends on delivering personalized, medically credible engagement at scale.
Agentic AI offers a step-change: it acts using approved data and business rules to streamline marketing execution, speed up MLR reviews, and support field teams in real time, all fully compliant. Early results speak for themselves: up to 90% lower campaign testing costs, 60% faster MLR cycles, and a 10:1 ROI on field engagement.
For leaders, this marks a transition from isolated marketing improvements to a connected performance engine that links insights directly to execution.
AI for Health conference replays on the CEO Stage are available
PROGRAM
Paul Hudson, CEO of SANOFI
“Fireside chat: The Future of AI in Health”
Olivier Laureau, CEO of SERVIER– Virginie Dominguez, Executive VP Information Systems, Digital, Data & AI at SERVIER
“AI Serving Patients: From Target to Treatment”
AI for Health conference replays of the Main Stage
PROGRAM
Dr. Tedros Adhanom Ghebreyesus, Director General of the World Health Organization – Sébastien Marguerès, Director AI for Health & Public Affairs at ARTEFACT
“AI for Health Grand Palais Opening Ceremony”
Prof. Stéphanie Allassonnière, Vice President Valorisation & Chair of the Prairie Institute at UNIVERSITY PARIS CITE– Mathilda Ström, Founding Chief Operating Officer at BIOPTIMUS–Prof. Ian Abbs, Strategic Advisor, Former CEO of Guy’s and St Thomas’ NHS Foundation Trust – Emma Charles, Senior Vice President European Markets at BRISTOL MYERS SQUIBB – Arafat Mlika, Global Sales Leader & Life Sciences Business Development Lead at AWS
“Agents: The AI-Powered Path to Improve Patients’ Outcomes”
Walid Mehanna, Chief Data & AI Officer, at MERCK GROUP – Emre Ozcan, Global Head of Digital Health & Devices at MERCK GROUP
“Redefine the Future of Health: Leading with AI”
Dr. Grégoire Pigné, CEO & Co-Founder, Oncologist Radiotherapist at PULSELIFE– Dr. Olivier Véran, Former French Minister of Social Affairs and Health & Former Government Spokesperson, CEO & Founder of INNOV– Peter Schardt, CTO at SIEMENS HEALTHINEERS – Dr. Nasheed Jamal, CMO at BIOSERENITY – Reda Guiha, Country President France at PFIZER
“Bridging AI Innovation From Bench to Bed”
Anwar Dahab, Senior VP & Managing Director France at DELL TECHNOLOGIES – Paul Rinaudo, CEO & Founder of ADLIN SCIENCE – Prof. David Morquin, Head of AI Strategy & Data Governance at MONTPELLIER HUC – Anne
Ferrer-Villeneuve, Managing Director at MONTPELLIER HUC
“Transforming Hospitals Through On-Premise Generative AI”
Arthur Delapalme, CEO & Co-Founder of CODOC– Dr. Virginie Pichon, Neurologist & Rare Disease Network Expert at ANGERS UHC – Prof. Philippe Codron, Professor & Neurologist at ANGERS UHC – Susanna Cirulli, Programme Manager EMEA at HIMSS– Thibaud Guymard, Head of Innovation, Services & Digital at BIOGEN
“From Innovation to Clinical Impact: New Approaches for AI in Rare Diseases”
Prof. Pierre-Antoine Gourraud, Professor & Healthcare Practitioner at NANTES UHC – Dr. Solène Vo Quang, Surgeon, CEO & Founder of HACK YOUR CARE – Prof. Antoine Tesnière, Managing Director at PARISANTÉ CAMPUS – Dr. Michael Lauk, Chief Digital Officer at B. BRAUN
“Smart Hospitals: Infrastructure & Tools for Tomorrow’s Healthcare”
Olivier Laureau, President & CEO of SERVIER – Virginie Dominguez, Executive VP, Information Systems, Digital, Data & AI at SERVIER – Brice Miranda, Chief Data & AI Officer at SERVIER– Ahmad Murtada, Chief Digital Transformation Officer at SERVIER–
“Servier Hackathon Award Ceremony”
Sébastien Marguerès, Director AI for Health & Public Affairs at ARTEFACT
“AI for Health Day 2 – Opening Words”
Jan Beger, Global Head of AI Advocacy at GE HEALTHCARE
“Human. Machine. Care”
Pascaline Villié, Project Director, Innovation & Data Division at AP-HP – Amaury Martin, Chief Innovation & Growth Officer at INSTITUT CURIE – Sophie Ollivier, Chief Data Officer R&D at SERVIER– Benjamin Garel, CEO of Paris Saclay Cancer Cluster
“The Midas Touch: Transforming Real-World Oncology Data Through Collective Intelligence”
Dr. Eva-Maria Hempe, Executive Director Healthcare & Life Sciences EMEA at NVIDIA–Jan Beger, Global Head of AI Advocacy at GE HEALTHCARE – Brian Gruttadauria, Chief Technology Officer, Hybrid Cloud at HPE– Sébastien Marguerès, Director AI for Health & Public Affairs at ARTEFACT
“The Clinical AI Shift: How Hospitals Are Moving from Pilots to Practice”
Paul S. Addison, Chief Scientist for Data Science & AI at MEDTRONIC– Patrick Pérez, CEO of KYUTAI– Hela Ghariani, Co-Head of the French Ministerial Delegation for e-Heath – Hugo Ceulemans, Senior Director – Drug Discovery Data Sciences at J&J INNOVATIVE MEDICINE – Paul de Balincourt, Partner at ARTEFACT
“From Science to Solutions, AI Adoption as the Key to Next-Generation Health”
Marie Morice-Morand, Associate Director of Innovation & Digital at AMGEN– Dr. Nicolas Gatulle, CEO & Co-Founder of PAPERDOC – Axel Voss, Member of the European Parliament – Mohamed-Ramzi Temanni, Global Executive in AI & Life Sciences
“Smarter Care, Stronger Ecosystems: How AI Becomes the Co-Pilot of Healthcare Transformation”
Adrien Coulet, Researcher & Co-Lead of HeKA, a Joint Inria-Inserm Lab at INRIA– Nacim Rahal, Vice President, Data & AI at DOCTOLIB– Dr. Derya Şahin, Data & AI in Health Specialist, Physician at WOLRD BANK GROUP / OECD.AI – Maria Duloquin, Innovation Facilitator, Master of Ceremony AI for Health
“Redefining Health Through the Patient’s Power”
David Cahané, General Manager & Co-founder of BIOPTIMUS – Prof. Charlotte Bunne, Professor of Computer Science & Life Sciences at EPFL– Thomas Fuchs, Senior Vice President & Chief AI Officer at ELI LILLY – Szabolcs Nagy, CEO & Co-Founder of TURBINE – Loïc Chabanier, Europe West Health Leader at EY
“Boosting Drug Discovery with Agents & Digital Twins”
Saila Rinne, Head of Unit “Artificial Intelligence in Health & Life Sciences” at the EU AI Office at the EUROPEAN COMMISSION – Prof. Petra Ritter, Coordinator at TEF-HEALTH – Marion Abecassis, Attorney, Counsel in Life Sciences at DLA PIPER – Francesca Colombo, Head of Health Division at OECD – Prof. Hiroki Habuka, Research Professor at KYOTO UNIVERSITY
“Rethinking How We Regulate & Evaluate Health Technologies in the AI Era”
David Cahané, General Manager & Co-founder of BIOPTIMUS – Prof. Céline Hudelot, Head of the MICS Laboratory at CENTRALESUPÉLEC– Prof. Stéphanie Allassonnière, VP Valorisation & Chair of the Prairie Institute at UNIVERSITY PARIS CITÉ – Prof. Pierre-Antoine Gourraud, Professor & Healthcare Practitioner at NANTES UHC – Dr. Kévin Yauy, Physician & PhD in AI, Head of the GenAI in Health Lab – ERIOS at MONTPELLEIR UHC – Prof. Antoine Tesnière, Managing Director of PARISANTÉ CAMPUS – Dr. Raphaëlle Parker, Expert in AI for Health
“Call for Abstracts Award Ceremony”
Thomas Clozel, Chief Biology ASI &
Co-Founder of OWKIN
“The Future of AI for Life”
AI for Health conference replays of the Masterclass Stage
PROGRAM
Dr. Cécile Teinturier, Pediatric Endocrinologist at BICÊTRE HOSPITAL AP-HP – Imogen Marouillat, Head of Solution Delivery for Global Digital Health at MERCK– David Braun, Head of Commercial Operations & Customer Engagement for Global Digital Health at MERCK– Fulvio Michelis, Digital Health Product Owner for Global Digital Health at MERCK
“How AI Is Reshaping Care in Rare Diseases & Endocrinology?”
Régis Dioulo, Healthcare Lead France at NVIDIA– Yves Mahieu, International Industry Principal, Healthcare & Life Sciences at PURE STORAGE
“Enabling the European Health Data Space (EHDS)”
Marco Giannitrapani, Vice President Global Data & Analytics at NOVARTIS
“Leveraging Data, Digital & AI to Better Serve Customers in Need”
Prof. Dean Ho, Head of the Department of Biomedical Engineering & Provost’s Chair Professor & Director at WisDM – National University of Singapore
“Digital Longevity Medicine”
Dr. Melvin Speisman, President of the American College of AI and Medicine – Dr. Andrea Slasuraitis, Vice President of the
American College of AI and Medicine
“AI Shaping a New Era of Chronic Disease Management”
Kaoutar Sghiouer, Group Chief Data & AI Officer at SANOFI – Aditya Kudumala, Partner & Global AI Lead for Life Sciences at DELOITTE
“Scaling Agentic AI in a World-Leading Pharma Company”
Tiziana Tocci, PhD Candidate at INSTITUT CURIE – Hasti Honari, PhD Candidate at INSTITUT CURIE – Balthazar Raffy, Bioinformatician at MSINSIGHT– Bora Guloglu, Senior Research Scientist at INSTADEEP– Dr. Arman Gorji, Co-Founder & Head of NAIRG (Neuroscience & Neoplasia AI Research Group)– Ulysse Gimenez, Data Science Director at BIOSERENITY
“Call for Abstracts Scientific Session”
Hicham Temsamani, Principal of H.B.T Group France– Marc Deloger, Data Team Lead at INSTITUT GUSTAVE ROUSSY – Prof. Fabrice Denis, Director, Professor, Oncologist, Preventive & Longevity Medicine at INSTITUT ASTRIUM – Emmanuel Canes, Healthcare & Life Sciences Director – Southern Europe at DELL TECHNOLOGIES
“Digital Twins in Oncology: Curative & Preventive, Same Foundations?”
Pierre Emerich, Chief Technology Officer at BIOSERENITY
“When AI Reads Brainwaves: Unlocking the Hidden Vital Sign”
Marguerite Brac de La Perrière, Partner, Attorney, Tech & Data, Digital Health at FIELDFISHER
“Striking Gold: The Untapped Potential of Health Data Reuse”
Evelyne Kratz, Health Sciences and Digital Health Senior Consultant & Speaker at E-health Conferences and Workshops & Digital Health Lecturer – Alexandre Le Bouthillier, CEO & Co-Founder at LINEARIS
“From Reactive to Proactive: Personalized Healthcare for All”
Line Linstad, Director at Norwegian Centre for E-health Research – Eric Sutherland, Senior Health Economist at OECD
“Navigating Dilemmas: Public-Private Partnerships to Enable the Responsible Scale of AI”
Kevin Carvalho, Head of Partnerships at DEEPLIFE– Paul Rinaudo, CEO & Founder of ADLIN SCIENCE – David Del Bourgo, CEO & Co-Founder of WHITELAB GENOMICS – Timothé Cynober, Global Head of BD&L at WHITELAB GENOMICS – Hedi Ben Brahim, CEO of ONE BIOSCIENCES – Vincent Puard, CEO & Co-Founder of MABSILICO– Frédéric Parmentier, Vice President Data Science at ARIANA PHARMA
“TechBio Revolution: Redefining Therapeutic R&D at the Nexus of AI & Biology”
Léa Giroulet, Consulting Manager at ARTEFACT– Thomas Filaire, Partner at ARTEFACT– Anna Sojnóczky, Consulting Manager at ARTEFACT
“Agentic AI: Accelerating Pharma’s HCP-Centric Marketing from Insight to Outcome”
AI for Health conference replays of the Start-up Stage
PROGRAM
Shana Owen, Strategic Partnerships & Key Client Manager at VIVANTI
“Driving Efficiency: AI Solutions for the Field Force Evolution”
Bertrand Spilthooren, Digital-health strategist & team manager TUNE INSIGHT
“How to boost collaboration on health data… without exposing sensitive information?”
Antoine De Torcy, Chief AI & Product Officer at BIOLEVATE
“Why chatbots are the worst way to use GenAI?”
Charles Rollet, CEO of TRACEX
“How human–AI agents collaboration in all-in-one platforms will speed up time-to-market for medical device companies”
Paul Rinaudo, CEO & Founder of ADLIN SCIENCE – Adel Houhou, Business Development Manager at ADLIN SCIENCE
“Multi-modal data structuration: why data is the next bottleneck of AI development?”
Elisa Negra, Co-CEO & Co-founder of SPARTA CARE
“Understanding the CE Marking Challenges of LLM-based Medical Devices”
Jai’ Amir Ramjankhan, Co-Founder of APURA CLOUD
“Building Trust in AI: The Role of Data Ownership and Sovereignty”
Dmitry Pavlotsky, Co-Founder & CMO at GAME ANALYZE
“Use of AI gamification to discover behavioral patterns of children”
Tackeun KIM, CEO & Neurosurgeon at TALOS
“Prevent the Preventable: AI for Early Detection”
Hannes Klöpper, CEO & Founder of HELLOBETTER
“Responsibly deploying AI in mental health”
Pierrick Arnal, CEO of OKEIRO
“From Data to Decision: AI-Driven Precision Medicine for Organ Transplant Management”
Boris Liniere, Co-Founder of SECOND BRAIN
“The End of Commercial and Medical Field Engagement as We Know It”
Rakia Jaziri, CEO & Co-founder of WEALTHY TECHNOLOGY
“Agentic AI for Faster and Smarter Drug Approvals”
Anne Maheust, CEO of USE & SHARE
– Stephan Cohen-Bacrie, Expert in semantic interoperability at USE & SHARE
“Health data without borders”
Soham Saha, President & CEO of MEDINSIGHTS–Manish Sarkar, Head of Business development at MEDINSIGHTS
“AI-powered forecasting for clinical trials to enhance clinical development efficiency”
Dr. Prasun Chakraborty, CEO & Founder of GENEVATION
“Integrating Artificial Intelligence to Accelerate Development of Patient-Specific Cancer Vaccines”
Read the Report of the CEO Stage at Adopt AI with the Replays and Summaries of each presentation
We are proud to share with you the replays of all the CEOs who took the stage at Adopt AI and delivered outstanding value to the summit. Their vision, strategic perspectives, and real-world experience have been invaluable in inspiring organizations to shape and accelerate their AI roadmaps. The report follows the 2-day program of the CEO Stage.
